Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden. - Widén J; Ivarsson M; Schalin L; Vrouchou P; Schwenkglenks M; Heimbürger O; Ademi Z; Sutherland CS (PharmacoEconomics, 2020)